Those taking a 10mg dose experienced a 19.5% reduction, while participants on a 15mg dose saw a 20.9% reduction
Shapely is an in-network provider with Aetna, making it easier for members to access expert-led, insurance-covered weight loss care
Recent animal studies have examined how to treat senescent cells with therapies such as the FOXO4-DRI peptide
The results of the analysis of nearly 10,000 people at high risk, indicated improvements in all the key areas of interest, including "HbA1c (0.87 percentage points), body weight (2.54%), systolic blood pressure (SBP, 3.84 mm Hg), pulse pressure (3.81 mm Hg), hsCRP (18.08%), total cholesterol (TC, 7.00%), nonhigh-density lipoprotein cholesterol (nonHDL-C, 8.02%), HDL-C (4.49%), and triglycerides (8.15%)